Stay updated on Nivolumab vs Ipilimumab in Melanoma Recurrence Prevention Clinical Trial

Sign up to get notified when there's something new on the Nivolumab vs Ipilimumab in Melanoma Recurrence Prevention Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab vs Ipilimumab in Melanoma Recurrence Prevention Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    Removed related topics entries for Melanoma and MedlinePlus Genetics from the Related Topics section.
    Difference
    0.1%
    Check dated 2025-12-05T02:46:25.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    Related topics Melanoma and MedlinePlus Genetics were added to the page, and the revision version was updated from v3.3.1 to v3.3.2.
    Difference
    0.1%
    Check dated 2025-11-28T01:18:06.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    Added a note that publications are automatically filled from PubMed. Updated the page revision to v3.3.1 and removed older PubMed-related wording (v3.2.0).
    Difference
    0.1%
    Check dated 2025-11-20T22:09:18.000Z thumbnail image
  5. Check
    32 days ago
    Change Detected
    Summary
    Removal of the government funding status banner; the page's study content and navigation remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2025-11-13T15:42:36.000Z thumbnail image
  6. Check
    46 days ago
    Change Detected
    Summary
    - Added a new citation under Publications From PubMed: Nivolumab for Resected Stage III or IV Melanoma at 9 Years, N Engl J Med, 2025 Oct 18. - No other page content was altered.
    Difference
    0.2%
    Check dated 2025-10-30T11:07:33.000Z thumbnail image
  7. Check
    61 days ago
    Change Detected
    Summary
    - Removed a MedlinePlus Genetics topic: Melanoma. This reduces coverage of that specific melanoma-related genetics topic on the page.
    Difference
    0.1%
    Check dated 2025-10-16T05:51:13.000Z thumbnail image

Stay in the know with updates to Nivolumab vs Ipilimumab in Melanoma Recurrence Prevention Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab vs Ipilimumab in Melanoma Recurrence Prevention Clinical Trial page.